Bioxytran BIXT
OTC BIXT
$0.02 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Bioxytran (BIXT) Change in Accured Expenses (2010 - 2026)

Updated

Bioxytran's Change in Accured Expenses came in at $133,181 for Q2 2026, down 6.5% from $142,490 a year earlier and down 38.3% from the prior quarter.

Analysis

Bioxytran (BIXT) Change in Accured Expenses (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Bioxytran reported Change in Accured Expenses of $540,905; for FY2025, it was $495,921, up 92.1% from FY2024.

  • Change in Accured Expenses carries a five-year compound annual growth rate of 12.4% (FY2020 to FY2025).
  • Going back by year, Change in Accured Expenses was $258,206 in FY2024, -$214,429 in FY2023, $129,508 in FY2022 (-89.3%) and $1.21 million in FY2021 (+336.7%).
  • The five-year range for quarterly Change in Accured Expenses is -$603,795 (Q3 2024) to $892,239 (Q4 2021).
  • Year-over-year, Change in Accured Expenses increased in 1 of the last four quarters, with an average decline of 17.0%.
  • The fastest year-over-year change in Change in Accured Expenses over five years came in Q4 2021 (growth of 607.7%), and the weakest in Q2 2025 (a decline of 71.6%).
  • Business Quant data shows BIXT's Change in Accured Expenses at $215,868 (Q1 2026), -$199,257 (Q4 2025) and $391,113 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 2.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 1.20 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 338.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Bioxytran 2.29 Mn 1.13 Mn - 133,181.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 133,181.00
Mar 31, 2026 215,868.00
Dec 31, 2025 -199,257.00
Sep 30, 2025 391,113.00
Jun 30, 2025 142,490.00
Mar 31, 2025 161,575.00
Dec 31, 2024 149,117.00
Sep 30, 2024 -603,795.00
Jun 30, 2024 502,372.00
Mar 31, 2024 210,512.00
Dec 31, 2023 -5,656.00
Sep 30, 2023 -102,091.00
Jun 30, 2023 -458,156.00
Mar 31, 2023 351,474.00
Dec 31, 2022 412,313.00
Sep 30, 2022 -215,324.00
Jun 30, 2022 40,695.00
Mar 31, 2022 -108,176.00
Dec 31, 2021 892,239.00
Sep 30, 2021 95,998.00
API Access

Bioxytran Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=BIXT&period=max&api_key=YOUR_API_KEY